Showing 61 - 80 results of 8,986 for search '(((( 50 ppm decrease ) OR ( 50 ((ns decrease) OR (we decrease)) ))) OR ( 50 μ decrease ))', query time: 0.86s Refine Results
  1. 61
  2. 62
  3. 63
  4. 64
  5. 65
  6. 66
  7. 67
  8. 68

    Image_1_Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.tif by Zijing Ran (11429935)

    Published 2021
    “…</p>Results<p>ULT resulted in a mean (standard deviation) decrease in SU level (464.22 ± 110.21 μmol/L at baseline, 360.93 ± 91.66 μmol/L at the final visit, p <0.001) accompanied by a decrease in median (interquartile range) VFA [97.30 (81.15–118.55) at baseline, 90.90 (75.85–110.05) at the final visit, p < 0.001]. …”
  9. 69

    The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties. by Wangyong Shin (6793040)

    Published 2020
    “…(F) The GluN2B-C456Y mutation decreases the sensitivity to glycine. <i>n</i> = 4 oocytes for WT (EC<sub>50</sub> = 0.38 ± 0.017 μM) and 9 oocytes for C456Y (EC<sub>50</sub> = 1.13 ± 0.049 μM), **<i>P</i> = 0.007, Mann-Whitney. …”
  10. 70
  11. 71
  12. 72
  13. 73

    Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

    Published 2025
    “…<b>(B)</b> A significant decrease in the proliferative clonal capacity of U251MG colonies was observed with 50ΜM and 100ΜM SHG-44 treatment. …”
  14. 74
  15. 75

    Decreased phosphorylation of EIF2α underlies the impairment of arsenite-induced SG formation in LSM12-depleted cells. by Jongbo Lee (9914603)

    Published 2020
    “…Control<sup>shRNA</sup> and <i>LSM12</i><sup>shRNA</sup> cells were incubated with 50-μM NaAsO<sub>2</sub>, 1-μM thapsigargin (Tg), or 0.4-M sorbitol for the indicated time before harvest. …”
  16. 76

    DataSheet_1_Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.docx by Zijing Ran (11429935)

    Published 2021
    “…</p>Results<p>ULT resulted in a mean (standard deviation) decrease in SU level (464.22 ± 110.21 μmol/L at baseline, 360.93 ± 91.66 μmol/L at the final visit, p <0.001) accompanied by a decrease in median (interquartile range) VFA [97.30 (81.15–118.55) at baseline, 90.90 (75.85–110.05) at the final visit, p < 0.001]. …”
  17. 77
  18. 78
  19. 79
  20. 80